SkinHealth Systems Inc. Class A Common Stock (SKIN) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, SKIN trades at $0.65 with a market cap of $78.49M and a P/E ratio of -13.92. SKIN moved +4.00% today. Year to date, SKIN is -51.95%; over the trailing twelve months it is -59.91%. Its 52-week range spans $0.55 to $2.69. Analyst consensus is neutral with an average price target of $1.63. Rallies surfaces SKIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SkinHealth Systems Q1 Revenue Falls 6.7% to $64.9M; Adjusted EBITDA Rises 16%: SkinHealth Systems reported Q1 2026 net sales of $64.9 million, down 6.7% year-over-year, driven by declines in delivery system and consumables sales. Net loss narrowed to $6.6 million while adjusted EBITDA climbed to $8.5 million as operating expenses fell 24%.
| Metric | Value |
|---|---|
| Price | $0.65 |
| Market Cap | $78.49M |
| P/E Ratio | -13.92 |
| EPS | $-0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.69 |
| 52-Week Low | $0.55 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $296.12M |
| Net Income | $-6.05M |
| Gross Margin | 64.91% |
5 analysts cover SKIN: 0 strong buy, 1 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.63.